RXO, Inc. (RXO) stock
Close on Nov 16, 2026Market cap $4.68BP/E –Yield –
Earnings
RXO's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of RXO's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 5, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026before the open | $1.90B | +35.7% | $0.02 | $0.09 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026before the open | $1.80B | +28.6% | -$0.05 | $0.06 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026before the open | $1.40B | 0.0% | -$0.21 | -$0.09 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 6, 2026before the open | $1.50B | -11.8% | -$0.27 | -$0.07 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025before the open | $1.40B | +34.6% | -$0.08 | $0.01 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025before the open | $1.40B | +50.5% | -$0.05 | $0.04 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025before the open | $1.40B | +55.6% | -$0.18 | -$0.03 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 5, 2025before the open | $1.70B | +70.0% | -$0.12 | $0.06 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | $1.04B | +4.0% | -$1.81 | $0.05 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024before the open | $930.00M | -7.0% | -$0.06 | $0.03 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024before the open | $900.00M | -10.9% | -$0.13 | -$0.03 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 8, 2024before the open | $1.00B | -9.1% | $0.02 | $0.06 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023before the open | $1.00B | – | -$0.01 | $0.05 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023before the open | $1.00B | – | $0.03 | $0.08 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023before the open | $1.01B | – | $0.00 | $0.11 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 7, 2023after the close | $1.10B | – | -$0.03 | $0.28 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
RXO's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| adjusted EBITDAnon-GAAP | FY2027 | $500.00M | – | New | Feb 7, 2023 |
Guidance history
Every forecast RXO put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 6, 2026 | adjusted EBITDA | Q3 FY2026 | $35.00M – $45.00M | New |
| May 7, 2026 | adjusted EBITDA | Q2 FY2026 | $27.00M – $37.00M | New |
| Feb 6, 2026 | adjusted EBITDA | Q1 FY2026 | $5.00M – $12.00M | New |
| Feb 6, 2026 | gross margin | Q1 FY2026 | 11% – 13% | New |
| Feb 6, 2026 | overall volume | Q1 FY2026 | -10% – -5% | New |
| Nov 6, 2025 | adjusted EBITDA | Q4 FY2025 | $20.00M – $30.00M | New |
| Nov 6, 2025 | gross margin | Q4 FY2025 | 12% – 13% | New |
| Aug 7, 2025 | adjusted EBITDA | Q3 FY2025 | $33.00M – $43.00M | New |
| Aug 7, 2025 | gross margin | Q3 FY2025 | 13.5% – 15% | New |
| May 7, 2025 | adjusted EBITDA | Q2 FY2025 | $30.00M – $40.00M | New |
| May 7, 2025 | Brokerage gross margin | Q2 FY2025 | 13% – 15% | New |
| Feb 5, 2025 | adjusted EBITDA | Q1 FY2025 | $20.00M – $30.00M | New |
| Feb 5, 2025 | Brokerage gross margin | Q1 FY2025 | 12% – 14% | New |
| Nov 7, 2024 | adjusted EBITDA | Q4 FY2024 | $40.00M – $45.00M | New |
| Nov 7, 2024 | Brokerage gross margin | Q4 FY2024 | 12% – 14% | New |
| Aug 7, 2024 | companywide adjusted EBITDA | Q3 FY2024 | $28.00M – $34.00M | New |
| Aug 7, 2024 | Brokerage gross margin | Q3 FY2024 | 13% – 15% | New |
| May 2, 2024 | companywide adjusted EBITDA | Q2 FY2024 | $24.00M – $30.00M | New |
| May 2, 2024 | brokerage gross margin | Q2 FY2024 | 13% – 15% | New |
| Feb 7, 2023 | adjusted EBITDA | FY2027 | $500.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases RXO filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Update
- Results
- Results
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?